US Stock MarketDetailed Quotes
IMNPQ Immune Pharmaceuticals, Inc.
- 0.001000
- 0.0000000.00%
15min DelayClose Oct 25 09:30 ET
172.88KMarket Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.001000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)172.88MShares0.00100052wk High0.20P/B172.56KFloat Cap0.00100052wk Low--Dividend TTM172.56MShs Float0.179000Historical High--Div YieldTTM0.00%Amplitude0.000100Historical Low--Avg Price1Lot Size
Immune Pharmaceuticals, Inc. Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2018 | (Q2)Jun 30, 2018 | (Q1)Mar 31, 2018 | (FY)Dec 31, 2017 | (Q4)Dec 31, 2017 | (Q3)Sep 30, 2017 | (Q2)Jun 30, 2017 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||||
| Gross profit | |||||||
| Operating expense | 30.26%3.7M | 2.12%2.84M | 4.33M | 12.12M | 3.81M | 2.84M | 2.78M |
| Selling and administrative expenses | 2.11%1.64M | -17.48%1.13M | --1.93M | --6.61M | --1.96M | --1.61M | --1.37M |
| -General and administrative expense | 2.11%1.64M | -17.48%1.13M | --1.93M | --6.61M | --1.96M | --1.61M | --1.37M |
| Research and development costs | 67.13%2.05M | 21.03%1.72M | --2.39M | --5.52M | --1.84M | --1.23M | --1.42M |
| Operating profit | -30.26%-3.7M | -2.12%-2.84M | -4.33M | -12.12M | -3.81M | -2.84M | -2.78M |
| Net non-operating interest income expense | 65.42%-498K | 86.88%-281K | -65K | -3.66M | 982K | -1.44M | -2.14M |
| Non-operating interest expense | -65.42%498K | -86.88%281K | --65K | --3.66M | ---982K | --1.44M | --2.14M |
| Other net income (expense) | 103.61%64K | -15,830.00%-1.59M | 7K | -4.08M | -2.3M | -1.77M | -10K |
| Gain on sale of security | -90.53%9K | --12K | --26K | --177K | --82K | --95K | ---- |
| Special income (charges) | --0 | ---472K | ---- | ---2.47M | ---325K | ---2.15M | --0 |
| -Less:Impairment of capital assets | --0 | --653K | ---- | ---- | ---- | --0 | --0 |
| -Less:Other special charges | ---- | ---181K | ---- | --2.15M | --0 | --2.15M | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---325K | ---- | ---- | ---- |
| Other non- operating income (expenses) | -80.22%55K | -11,230.00%-1.13M | ---19K | ---1.79M | ---2.06M | --278K | ---10K |
| Income before tax | 31.71%-4.13M | 4.44%-4.72M | -4.38M | -19.86M | -5.12M | -6.05M | -4.94M |
| Income tax | 0 | 0 | -1.97M | -1.97M | 0 | 0 | |
| Net income | 31.71%-4.13M | 4.44%-4.72M | -4.38M | -17.89M | -3.15M | -6.05M | -4.94M |
| Net income continuous Operations | 31.71%-4.13M | 4.44%-4.72M | ---4.38M | ---17.89M | ---3.15M | ---6.05M | ---4.94M |
| Minority interest income | |||||||
| Net income attributable to the parent company | 31.71%-4.13M | 4.44%-4.72M | -4.38M | -17.89M | -3.15M | -6.05M | -4.94M |
| Preferred stock dividends | |||||||
| Other preferred stock dividends | 5.54M | 5.6M | 6.86M | 6.86M | 0 | 0 | |
| Net income attributable to common stockholders | -59.86%-9.67M | -109.00%-10.32M | -4.38M | -24.75M | -10.01M | -6.05M | -4.94M |
| Basic earnings per share | 54.72%-0.24 | -68.00%-0.84 | -0.15 | -2.11 | -0.64 | -0.53 | -0.5 |
| Diluted earnings per share | 54.72%-0.24 | -68.00%-0.84 | -0.15 | -2.11 | -0.64 | -0.53 | -0.5 |
| Dividend per share | |||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg